KEILAR: A major development in the race for a coronavirus vaccine. The pharmaceutical company, Moderna, says it's now hit its target of 30,000 participants for its phase three vaccine trial. The company says all of those in rolled have received their first vaccine shot and most have also received the required second shot. Moderna's president said, if all the stars align, his company is now on track to apply to the FDA for authorization to put the vaccine on the market in early December. Now a CNN exclusive on Russia's push to develop a coronavirus vaccine. The developers of Russia's touted Sputnik-V coronavirus vaccine revealing to CNN the vaccine has not undergone the same rigorous testing required in other global trials. CNN's Fred Pleitgen is reporting from Moscow with exclusive details.</s>FRED PLEITGEN, CNN SENIOR INTERNATIONAL CORRESPONDENT: Hi there, Brianna. In August, the Russians approved their vaccine Sputnik-V without going through the main phase three trials for efficacy and for safety of the vaccine. However, the Russians kept on saying that they were going to conduct trials quickly. Last week, they said they'd already vaccinated 13,000 people. This week, they were saying 17,000 people. When we exclusively spoke to the head of the Gamaleya Institute, which is responsible for the Sputnik-V vaccine, the head of that institute told us, so far, only around 6,000 of those participants have actually received both doses of the vaccine. Which, of course, are key to achieving immunization and then for the scientists to be able to collect data from those trial participants. Now, another thing we've also learned is this vaccine, the institute says, is suitable for people between the ages of 18 and 60, and also not suitable for people who have various illnesses and also allergies as well. However, the head of the Gamaleya Institute says he believes it's still fine to also give the vaccine to older people and also to people with most illnesses. Of course, many prominent Russians have already taken the vaccine but one notable exception remains the Russian President Vladimir Putin, who, for months, has remained in isolation essentially inside a bubble -- Brianna?
Only 6,000 Participants Received Both Doses in Russia's Vaccine Trial.